Clinical Trial Update: Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 trial updating the use of Omega-3 Fat Emulsion (Omegaven) in infants with parenteral nutrition-associated liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition Associated Liver Disease

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Parenteral Nutrition Associated Liver Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-12-14